[1]
N. Garin and P. Arnold, “Life-Threatening Adverse Reaction after Self-Initiated, Off-Label Use of High Dose Nicotinamide for the Treatment of Friedreich’s Ataxia”, EJCRIM, vol. 2, no. 3, Jun. 2015.